An appeals court ruling that bars prosecution solely for speech promoting off-label use carries with it potential negative ramifications for the pharmaceutical industry, including liability under state consumer protection laws and greater government scrutiny of internal marketing documents. / “The Pink Sheet” February 11 2013 12:01 AM
Purchase report here
No comments:
Post a Comment